PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 49 filers reported holding PROQR THRAPEUTICS N V in Q4 2022. The put-call ratio across all filers is 1.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $358,874 | +398.4% | 96,993 | -0.0% | 0.01% | +600.0% |
Q3 2022 | $72,000 | -5.3% | 97,019 | -0.8% | 0.00% | 0.0% |
Q2 2022 | $76,000 | -14.6% | 97,827 | -0.0% | 0.00% | 0.0% |
Q1 2022 | $89,000 | -99.2% | 97,851 | -92.9% | 0.00% | -98.4% |
Q4 2021 | $11,047,000 | +14.5% | 1,379,123 | +19.6% | 0.06% | +26.0% |
Q3 2021 | $9,650,000 | +176.0% | 1,152,912 | +122.3% | 0.05% | +194.1% |
Q2 2021 | $3,496,000 | – | 518,733 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
Atom Investors LP | 18,522 | $68,531 | 0.03% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |